ranbaxy reports loss sees 10 sales rise
Last Updated : GMT 09:07:40
Egypt Today, egypt today
Egypt Today, egypt today
Last Updated : GMT 09:07:40
Egypt Today, egypt today

Ranbaxy reports loss, sees 10% sales rise

Egypt Today, egypt today

Egypt Today, egypt today Ranbaxy reports loss, sees 10% sales rise

Mumbai - Arabstoday

Ranbaxy Laboratories, India’s biggest drug maker by revenue, said it expects sales to increase by at least 10 per cent in 2012 as it takes advantage of expiring drug patents in the United States, its biggest market.   Ranbaxy, which launched a generic version of cholesterol drug Lipitor in the US market in December, reported a fourth-quarter loss equivalent to $606 million. Sales, however, soared 79.2 per cent to $759.37 million in the quarter to Dec.31 from a year earlier, and were up 16.6 per cent at $2.02 billion for the full year.

egypttoday
egypttoday

Name *

E-mail *

Comment Title*

Comment *

: Characters Left

Mandatory *

Terms of use

Publishing Terms: Not to offend the author, or to persons or sanctities or attacking religions or divine self. And stay away from sectarian and racial incitement and insults.

I agree with the Terms of Use

Security Code*

ranbaxy reports loss sees 10 sales rise ranbaxy reports loss sees 10 sales rise



 
 Egypt Today Facebook,egypt today facebook  Egypt Today Twitter,egypt today twitter Egypt Today Rss,egypt today rss  Egypt Today Youtube,egypt today youtube  Egypt Today Youtube,egypt today youtube

Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©

Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©

egypttoday egypttoday egypttoday egypttoday
egypttoday egypttoday egypttoday
egypttoday
بناية النخيل - رأس النبع _ خلف السفارة الفرنسية _بيروت - لبنان
egypttoday, Egypttoday, Egypttoday